Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.

Wu Z, Todorov I, Li L, Bading JR, Li Z, Nair I, Ishiyama K, Colcher D, Conti PE, Fraser SE, Shively JE, Kandeel F.

Bioconjug Chem. 2011 Aug 17;22(8):1587-94. doi: 10.1021/bc200132t. Epub 2011 Jul 14.

PMID:
21692471
2.

Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.

Selvaraju RK, Velikyan I, Asplund V, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Eriksson B, Korsgren O, Eriksson O.

Nucl Med Biol. 2014 Jul;41(6):471-6. doi: 10.1016/j.nucmedbio.2014.03.017. Epub 2014 Mar 29.

PMID:
24857864
3.

Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.

Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F.

J Nucl Med. 2013 Feb;54(2):244-51. doi: 10.2967/jnumed.112.109694. Epub 2013 Jan 7.

4.

(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.

Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti PS, Li Z, Kandeel F.

Theranostics. 2014 May 24;4(8):770-7. doi: 10.7150/thno.7759. eCollection 2014.

5.

Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.

Bandara N, Zheleznyak A, Cherukuri K, Griffith DA, Limberakis C, Tess DA, Jianqing C, Waterhouse R, Lapi SE.

Mol Imaging Biol. 2016 Feb;18(1):90-8. doi: 10.1007/s11307-015-0861-5.

6.

64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Aug 24 [updated 2012 Mar 15].

7.

Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.

Xu Y, Pan D, Xu Q, Zhu C, Wang L, Chen F, Yang R, Luo S, Yang M.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1479-88. doi: 10.1007/s00432-014-1701-8. Epub 2014 May 17.

PMID:
24838847
8.

In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.

Selvaraju RK, Velikyan I, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Korsgren O, Eriksson O.

J Nucl Med. 2013 Aug;54(8):1458-63. doi: 10.2967/jnumed.112.114066. Epub 2013 Jun 12.

9.

Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4.

Eriksson O, Rosenström U, Selvaraju RK, Eriksson B, Velikyan I.

Acta Diabetol. 2017 Nov;54(11):1039-1045. doi: 10.1007/s00592-017-1046-2. Epub 2017 Sep 11.

10.

In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.

Brand C, Abdel-Atti D, Zhang Y, Carlin S, Clardy SM, Keliher EJ, Weber WA, Lewis JS, Reiner T.

Bioconjug Chem. 2014 Jul 16;25(7):1323-30. doi: 10.1021/bc500178d. Epub 2014 Jun 13.

11.

Evaluation of [68Ga]DO3A-VS-Cys40-Exendin-4 as a PET Probe for Imaging Human Transplanted Islets in the Liver.

Li J, Rawson J, Chea J, Tang W, Miao L, Sui F, Li L, Poku E, Shively JE, Kandeel F.

Sci Rep. 2019 Apr 5;9(1):5705. doi: 10.1038/s41598-019-42172-3.

12.

18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.

Kiesewetter DO, Gao H, Ma Y, Niu G, Quan Q, Guo N, Chen X.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):463-73. doi: 10.1007/s00259-011-1980-0. Epub 2011 Dec 15.

13.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1345-55. doi: 10.1007/s00259-009-1363-y. Epub 2010 Jan 29.

14.

18F-Tetrazine-trans-cyclooctene-Cys40-exendin-4.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Feb 18 [updated 2013 Apr 25].

15.

Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.

Mi B, Xu Y, Pan D, Wang L, Yang R, Yu C, Wan W, Wu Y, Yang M.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):47-51. doi: 10.1016/j.bbrc.2016.01.184. Epub 2016 Feb 3.

PMID:
26850848
16.

Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.

Xu Q, Zhu C, Xu Y, Pan D, Liu P, Yang R, Wang L, Chen F, Sun X, Luo S, Yang M.

J Drug Target. 2015;23(9):813-20. doi: 10.3109/1061186X.2015.1020808. Epub 2015 Mar 11.

PMID:
25758750
17.

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M, Keil B, Christofori G, Reubi JC, Mäcke HR.

J Nucl Med. 2006 Dec;47(12):2025-33.

18.

Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.

Selvaraju RK, Bulenga TN, Espes D, Lubberink M, Sörensen J, Eriksson B, Estrada S, Velikyan I, Eriksson O.

Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):259-69. eCollection 2015.

19.

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.

Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage EN, Ahn JM, Kiesewetter DO, Chen X.

Mol Pharm. 2011 Oct 3;8(5):1775-82. doi: 10.1021/mp200141x. Epub 2011 Aug 19.

20.

Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass.

Cline GW, Zhao X, Jakowski AB, Soeller WC, Treadway JL.

Biochem Biophys Res Commun. 2011 Sep 2;412(3):413-8. doi: 10.1016/j.bbrc.2011.07.077. Epub 2011 Jul 28.

PMID:
21820405

Supplemental Content

Support Center